864756-35-4

864756-35-4 structure

Name: TC-MCH 7c
Chemical Name: 4-[(4-Fluorobenzyl)oxy]-1-{4-[2-(1-pyrrolidinyl)ethoxy]phenyl}-2( 1H)-pyridinone
CAS Number: 864756-35-4
Molecular Formula: C₂₄H₂₅FN₂O₃
Molecular Weight: 408.46500
Catalog: Signaling Pathways GPCR/G Protein MCHR1 (GPR24)
Create Date: 2017-09-12 06:51:59
Modify Date: 2025-09-16 22:19:03
TC-MCH 7c, a phenylpyridone derivative, is an orally available, selective and brain-penetrable MCH1R antagonist with an IC50 of 5.6 nM for hMCH1R[1]. TC-MCH 7c has Kis of 3.4 nM and 3.0 nM of human and mouse MCH1R, respectively[2].

Name	4-[(4-Fluorobenzyl)oxy]-1-{4-[2-(1-pyrrolidinyl)ethoxy]phenyl}-2( 1H)-pyridinone

Description	TC-MCH 7c, a phenylpyridone derivative, is an orally available, selective and brain-penetrable MCH1R antagonist with an IC50 of 5.6 nM for hMCH1R[1]. TC-MCH 7c has Kis of 3.4 nM and 3.0 nM of human and mouse MCH1R, respectively[2].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> MCHR1 (GPR24) Research Areas >> Metabolic Disease
Target	IC50: 5.6 nM (hMCH1R)[1] Ki: 3.4 nM (hMCH1R) and 3.0 nM (mouse MCH1R)[1]
In Vitro	TC-MCH 7c has an IC50 of 9.7 μM for MCH1R in [Ca2+]i mobilization[1]. TC-MCH 7c has IC50s of 23 nM and 9.0 μM for FLIPR and hERG, respectively[2].
In Vivo	TC-MCH 7c (oral; 3-30 mg/kg; once-daily for 1.5 months) exhibits excellent body weight reduction in a dose-dependent manner in DIO mice model[1]. TC-MCH 7c (oral; 3-30 mg/kg) with 30 mg/kg has plasma concentrations of 5.1, 1.8, and 0.7 μM at 2, 15, and 24 hours, respectively[2]. Animal Model: C57BL/6J DIO mice[1] Dosage: 3, 10 and 30 mg/kg Administration: Oral; once-daily for 1.5 months Result: Exhibited excellent body weight reduction in a dose-dependent manner. Animal Model: Diet-induced obesity mice[2] Dosage: 3, 10 and 30 mg/kg (Pharmacokinetic Analysis) Administration: Oral Result: Plasma concentrations at 2, 15, and 24 hours were 5.1, 1.8, and 0.7 μM, respectively.
References	[1]. Ito M, et al. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice. Eur J Pharmacol. 2009 Dec 10;624(1-3):77-83. [2]. Haga Y, et al. Discovery of novel phenylpyridone derivatives as potent and selective MCH1R antagonists. Bioorg Med Chem. 2011 Jan 15;19(2):883-93.

Molecular Formula	C₂₄H₂₅FN₂O₃
Molecular Weight	408.46500
Exact Mass	408.18500
PSA	43.70000
LogP	3.96810

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

864756-35-4	1314140-00-5
1211866-85-1	362512-81-0
149447-21-2	937039-45-7
1082739-92-1	847950-09-8
959705-64-7	827327-28-6
1824052-16-5	2377033-20-8
1213424-19-1	2648914-58-1
2171486-18-1	2138539-78-1
2171257-76-2	2171178-16-6
2138117-17-4	2169046-89-1